Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.

Article Details

Citation

Copy to clipboard

Ji H, Li H, Flinspach M, Poulos TL, Silverman RB

Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.

J Med Chem. 2003 Dec 18;46(26):5700-11.

PubMed ID

14667223 [ View in PubMed

]

Abstract

Selective inhibition of nitric oxide synthase (NOS) isoforms has great therapeutic potential in the treatment of certain disease states arising from the pathological overproduction of nitric oxide. In this study three structures of each NOS isoform were employed to examine selective regions in the active site using the GRID/CPCA approach. In the GRID calculations, 10 probes covering hydrophobic, steric, and hydrogen-bond-acceptor and -donor interactions were used to calculate the molecular interaction fields (MIFs) in the active site. The side chain flexibility of the residues and the grid spacings were considered at the same time. Consensus principal component analysis (CPCA) was applied to analyze the MIFs differences in the active site between the NOS isoforms. By combining the cutout tool with GRID/CPCA pseudofield differential plots, several selective regions in the active site were identified. The selectivity analysis showed that the most important determinants for NOS inhibitor selectivity are hydrophobic and charge-charge interactions. Twenty-five inhibitors of NOS were then docked into the active site using the program AutoDock3.0. The regions identified as being important for selectivity by this method are in excellent agreement with inhibitor structure-activity relationships. A rational usage of the selective region described in this work should make it possible to develop NOS isoform-selective inhibitors.

DrugBank Data that Cites this Article

Binding Properties

Drug	Target	Property	Measurement	pH	Temperature (°C)
L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide	Nitric oxide synthase, brain	Ki (nM)	330	N/A	N/A	Details
L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide	Nitric oxide synthase, endothelial	Ki (nM)	245000	N/A	N/A	Details
N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine	Nitric oxide synthase, brain	Ki (nM)	290	N/A	N/A	Details
N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine	Nitric oxide synthase, endothelial	Ki (nM)	524000	N/A	N/A	Details